Ligand Pharma (LGND) Announces that Glaxo (GSK) was Approved for Revolade Marketing in Europe
Tweet Send to a Friend
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that GlaxoSmithKline (NYSE: GSK) was granted marketing authorization from the European Commission (EC) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
